Search research articles
Contact Us
Filters
Showing results (531-540 of 659) with videos related to
Page
of 66
Sort By:
AEM Education and Training
|
May 20, 2024
Current gaps in emergency medicine core content education for oncologic emergencies: A targeted needs assessment
Monica K Wattana, Angela Lindsay, Moira Davenport, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1988
Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C
P A Wender, C M Cribbs, K F Koehler, et al.
Pancreas
|
November 5, 1999
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma
R M Mohammad, Y Li, A N Mohamed, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products
M G Kazanietz, X R Bustelo, M Barbacid, et al.
Bioorganic & Medicinal Chemistry
|
August 28, 2009
E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes
Robin K Pettit, George R Pettit, Ernest Hamel, et al.
Anticancer Research
|
June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate
Jianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Journal of Natural Products
|
May 5, 2011
Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units
George R Pettit, Thomas H Smith, Jun-Ping Xu, et al.
Cancer Letters
|
April 22, 1999
The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas
J M Bodily, D J Hoopes, B L Roeder, et al.
Journal of the National Cancer Institute
|
November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee
P A Philip, D Rea, P Thavasu, et al.
Molecular Pharmacology
|
February 17, 2001
Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin
R Bai, P Verdier-Pinard, S Gangwar, et al.
Page
of 66
Search research articles
Search
Showing results (531-540 of 659) with videos related to
Sort By:
Page
of 66
AEM Education and Training
|
May 20, 2024
Current gaps in emergency medicine core content education for oncologic emergencies: A targeted needs assessment
Monica K Wattana, Angela Lindsay, Moira Davenport, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1988
Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C
P A Wender, C M Cribbs, K F Koehler, et al.
Pancreas
|
November 5, 1999
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma
R M Mohammad, Y Li, A N Mohamed, et al.
The Journal of Biological Chemistry
|
April 15, 1994
Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products
M G Kazanietz, X R Bustelo, M Barbacid, et al.
Bioorganic & Medicinal Chemistry
|
August 28, 2009
E-Combretastatin and E-resveratrol structural modifications: antimicrobial and cancer cell growth inhibitory beta-E-nitrostyrenes
Robin K Pettit, George R Pettit, Ernest Hamel, et al.
Anticancer Research
|
June 25, 2003
Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate
Jianyi Hua, Yezhou Sheng, Kevin G Pinney, et al.
Journal of Natural Products
|
May 5, 2011
Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units
George R Pettit, Thomas H Smith, Jun-Ping Xu, et al.
Cancer Letters
|
April 22, 1999
The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas
J M Bodily, D J Hoopes, B L Roeder, et al.
Journal of the National Cancer Institute
|
November 17, 1993
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee
P A Philip, D Rea, P Thavasu, et al.
Molecular Pharmacology
|
February 17, 2001
Dolastatin 11, a marine depsipeptide, arrests cells at cytokinesis and induces hyperpolymerization of purified actin
R Bai, P Verdier-Pinard, S Gangwar, et al.
Page
of 66